LAUREN RIVERS: Open Payments
NPI 1386471365 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,798 in 109 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $387 · 2025 $1,798
Food & beverage: $1,798
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 37 | $395 |
| UCB, Inc. | 16 | $286 |
| ABBVIE INC. | 14 | $181 |
| Novartis Pharmaceuticals Corporation | 6 | $175 |
| Radius Health, Inc. | 5 | $139 |
| Mallinckrodt Hospital Products Inc. | 4 | $111 |
| Janssen Biotech, Inc. | 5 | $96 |
| Lilly USA, LLC | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 5 | $76 |
| ANI Pharmaceuticals, Inc. | 4 | $74 |
Products named: Bimzelx, SKYRIZI, COSENTYX, OTEZLA, ACTHAR, EVENITY, TREMFYA, TALTZ.
Industry payments across MS — which companies pay providers there.
